Home › NDC Lookup › Ingredients › Glycerin, Lidocaine, Petrolatum, And Phe... › 00573-2843-01
Preparation H Rapid Relief Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/g Cream — NDC 00573-2843-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Preparation H Rapid Relief Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/g Cream — NDC 0573-2843-01 (Billing 00573-2843-01)

by Haleon US Holdings LLC · 1 TUBE in 1 CARTON / 23 g in 1 TUBE

This is a package of Preparation H Rapid Relief Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/g Cream from Haleon US Holdings LLC, marketed since Nov 2018 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 00573-2843-01
🏷️ FDA NDC (as labeled) 0573-2843-01 billing pads the labeler segment with a zero
This package
Contains23 g in 1 tube Pack sizes2 compare ↓
Main listing for product 0573-2843 · Also comes in: 28 g 0573-2843-10
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0573-2843-01
Product NDC 0573-2843
11-digit billing NDC 00573284301
NCPDP billing unit GM — per gram (weight)
RxCUI 2642220
UNII 4T6H12BN9U, 04JA59TNSJ, PDC6A3C0OX, 98PI200987
Application # M015
SPL Set ID 699310e8-1a93-40b4-a8f4-a765be4a0cb1
Established class (EPC) Non-Standardized Chemical Allergen; Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production; Local Anesthesia
Chemical class Allergens; Glycerol; Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-11-01
Route TOPICAL
Dosage form CREAM
Substance PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; GLYCERIN; LIDOCAINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 89992004503720
GPI class Preparation H Rapid Relief
GCN Seq No 079821
GCN 46404
HICL code 045764
Ingredient (HICL) Lidocaine/Phenyl/Glycer/Petrol
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3D
Therapeutic class — specific (HIC3) Hemorrhoidal Preparations
AHFS code 12:12.04.00
AHFS class Alpha-Adrenergic Agonists (12:12)
FDB label name PREPARATION H RAPID-LIDO CREAM
FDB brand name Preparation H Rapid Rlf-Lidocn
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 079821
  • GCN: 46404
  • GPI-14 (Medi-Span): 89992004503720
  • HICL (First Databank): 045764
  • AHFS class code: 12:12.04.00
  • RxCUI (RxNorm): 2642220
Why two NDCs? The FDA registers this code as 0573-2843-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00573-2843-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name PREPARATION H RAPID-LIDO CREAM Ingredient Lidocaine/Phenyl/Glycer/Petrol
🧪 What is this product?

Preparation H Rapid Relief is a topical cream sold over the counter as an OTC monograph product. It contains petrolatum and glycerin, which function as moisturizers and skin protectants, along with lidocaine, a local anesthetic typically used to numb minor pain and itching. The product also contains phenylephrine hydrochloride, a decongestant that narrows blood vessels and is commonly included in products meant to reduce swelling and discomfort in the anal area.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 28 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00573-2843-01 You're viewing this Main listing 1 TUBE in 1 CARTON / 23 g in 1 TUBE 2018-11-01 — Active
00573-2843-10 0573-2843-10 1 TUBE in 1 CARTON / 28 g in 1 TUBE 2018-11-01 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 23 g in 1 tube.
What NDC number is used to bill for this package of Preparation H Rapid Relief Glycerin, Lidocaine, Petrolatum, and Phenylephrine Hydrochloride 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Walgreens Hemorrhoidal Pain Relief 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 00363-1217-01 Walgreens 28 g — — FDA listed —
Preparation H Rapid Relief 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/gthis 00573-2843-01 Haleon 1 tube — — FDA listed —
Kroger Hemorrhoid 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 30142-0713-01 Kroger 12 tubes — — FDA listed —
GoodSense Hemorrhoidal Pain Relief 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 50804-0317-01 Perrigo 1 tube — — FDA listed —
Hemorrhoidal With Lidocaine 144 mg/g; 50 mg/g; 2.5 mg/g; 150 mg/g 51316-0225-00 CVS 1 tube — — FDA listed —
Hemorrhoidal Cream with Lidocaine 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 69396-0181-01 Trifecta 1 tube — — FDA listed —
Curist Hemorrhoid Fissure Relief 15 g/100g; 5 g/100g; 14.4 g/100g; .25 g/100g 72559-0037-08 Little 170 g — — FDA listed —
DCH Hemorrhoidal 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 72839-0217-01 Derma 1 tube — — FDA listed —
Revivol Hemorrhoid and Fissure 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 72839-0295-01 Derma 1 tube — — FDA listed —
Bunnies Bum Soothing Hemorrhoidal 14.4 g/100g; 15 g/100g; .25 g/100g; 5 g/100g 84308-0161-02 FloCal 57 g — — FDA listed —
ElixirLidoFast Rapid Relief 150 mg/g; 2.5 mg/g; 144 mg/g; 50 mg/g 84546-0006-01 ELIXIR 1 tube — — FDA listed —
Dermatool Hemorrhoidal 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 84728-0413-01 Papalo 1 tube — — FDA listed —
Norms Hemorrhoid 5 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 85996-0173-00 Totally 5 pouches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Nov 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHaleon US Holdings LLC
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code00573
First marketedNov 2018
Product typeHuman Otc Drug
Portfolio405 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 46 words ▾

Uses for temporary relief of pain, soreness and burning helps relieve the local itching and discomfort associated with hemorrhoids temporarily shrinks hemorrhoidal tissue temporarily provides a coating for relief of anorectal discomforts temporarily protects the inflamed irritated anorectal surface to help make bowel movements less painful

⏱️ Dosage and Administration 65 words ▾

Directions adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before applying this cream. apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement children under 12 years of age: ask a doctor

⚠️ Warnings 153 words ▾

Warnings For external use only Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes difficulty in urination due to enlargement of the prostate gland Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression. When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put into the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days an allergic reaction develops the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 6 words ▾

Other information store at 20-25°C (68-77°F)

🧪 Active Ingredient 12 words ▾

Active Ingredients Glycerin 14.4% Lidocaine 5% Phenylephrine HCl 0.25% White petrolatum 15%

🧪 Inactive Ingredients 50 words ▾

Inactive ingredients aloe barbadensis leaf extract, anhydrous citric acid, butylated hydroxyanisole, carboxymethylcellulose sodium, cetyl alcohol, citric acid monohydrate, dexpanthenol, edetate disodium, glyceryl monostearate, methylparaben, mineral oil, polyoxyl lauryl ether, polyoxyl stearyl ether, propyl gallate, propylene glycol, propylparaben, purified water, sodium benzoate, stearyl alcohol, tocopherols excipient, vitamin E acetate, xanthan gum

🎯 Purpose 6 words ▾

Purposes Protectant Local anesthetic Vasoconstrictor Protectant

📄 Ask a Doctor Before Use If 26 words ▾

Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes difficulty in urination due to enlargement of the prostate gland

📄 Ask a Doctor or Pharmacist Before Use If 21 words ▾

Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression.

📄 When Using This Product 31 words ▾

When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put into the rectum by using fingers or any mechanical device or applicator

📄 Stop Use and Ask a Doctor If 41 words ▾

Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days an allergic reaction develops the symptom being treated does not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 15 words ▾

Questions or comments? Call weekdays 9 AM to 5 PM EST at 1-800-99PrepH or 1-800-997-7374

📄 Package Label / Principal Display Panel 64 words ▾

PRINCIPAL DISPLAY PANEL PREPARATION H ® New Benefit Now Reduces Swelling See new label RAPID RELIEF WITH LIDOCAINE HEMORRHOIDAL CREAM LIDOCAINE PHENYLEPHRINE HCl GLYCERIN WHITE PETROLATUM 5% HIGHEST STRENGTH LIDOCAINE AVAILABLE Rapid numbing relief of pain, itching & burning Reduces swelling & provides a soothing protective layer 1 TUBE | NET WT

0.75OZ (23 g) Preparation H Rapid Relief w PE 0.75 oz

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Preparation H Rapid Relief (this brand).

Top reported reactions

Haemorrhage4
Burning Sensation3
Diarrhoea2
Drug Hypersensitivity2
Fatigue2
Haemorrhoids2
Pain2

Reporter sex

18 reports
Male · 13%
Female · 88%

Serious outcomes

Hospitalization6
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 8 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Haleon US Holdings LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (00573-2843-10). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Haleon US Holdings LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00573-2840-10 · Haleon 00573-2868-10 · Haleon →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.